Review Article
Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures
| Name | Peptide sequence |
| PRL-2903 | H-4Fpa-c[Cys-Pal-DTrp-Lys-Tle-Cys]-Nal-NH2 | SB-710411 | H-Cpa-c[DCys-Pal-DTrp-Lys-Val-Cys]-Cpa-NH2 | BIM-23127 | H-D(2′)Nal-c[Cys-Tyr-DTrp-Orn-Val-Cys]-(2′)Nal-NH2 | BIM-23042 | H-DNal-c[Cys-Tyr-DTrp-Lys-Val-Cys]-(2′)Nal-NH2 | U-II | H-Glu-Thr-Pro-Asp-c[Cys-Phe-Trp-Orn-Tyr-Cys]-Val-OH | P5U | H-Asp-c[Pen-Phe-Trp-Orn-Tyr-Cys]-Val-OH | Urantide | H-Asp-c[Pen-Phe-DTrp-Orn-Tyr-Cys]-Val-OH | UFP-803 | H-Asp-c[Pen-Phe-DTrp-Dab-Tyr-Cys]-Val-OH | URP | H-Ala-c[Cys-Phe-Trp-Lys-Tyr-Cys]-Val-OH | Urocontrin | H-Bip-c[Cys-Bip-Trp-Lys-Tyr-Cys]-Val-OH | GSK248451 | H-Cin-c[DCys-Pal-DTrp-Orn-Val-Cys]-His-NH2 |
|
|